Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H24N2O.ClH |
Molecular Weight | 308.846 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCC1=NC(OCCN(C)C)=C2C=CC=CC2=C1
InChI
InChIKey=SEYCAKMZVYADRS-UHFFFAOYSA-N
InChI=1S/C17H24N2O.ClH/c1-4-5-9-15-13-14-8-6-7-10-16(14)17(18-15)20-12-11-19(2)3;/h6-8,10,13H,4-5,9,11-12H2,1-3H3;1H
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1907589 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11714893 |
|||
Target ID: CHEMBL1907591 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11714893 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
To the skin as a 0.5% oinment or lotion 2 to 4 times per day.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2169310
Various local anesthetics enhanced the incorporation of [3H]inositol into phosphoinositides in guinea pig cerebral cortical synaptoneurosomes. Dibucaine, QX-572 and dimethisoquin showed maximum stimulation at 100 microM. There was no correlation between local anesthetic activity, estimated by inhibition of the 22Na+ flux elicited by the sodium channel activator batrachotoxin, and the potency for stimulation of inositol incorporation.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL127643
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
C009146
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
C72742
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
17714
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
SUB04189MIG
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
m1118
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
SMP2689462
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
220-468-1
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
DTXSID6045373
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
2773-92-4
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY | |||
|
100000085250
Created by
admin on Fri Dec 15 15:14:18 GMT 2023 , Edited by admin on Fri Dec 15 15:14:18 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD